Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade A 130.92 0.65% 0.84
ABMD closed up 0.65 percent on Thursday, April 27, 2017, on 0 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: May 4

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Apr 27 Upper Bollinger Band Walk Other 0.00%
Apr 27 Slingshot Bullish Bullish Swing Setup 0.00%
Apr 26 Doji - Bearish? Reversal 0.65%
Apr 26 Upper Bollinger Band Walk Other 0.65%
Apr 26 Cup with Handle Other 0.65%
Apr 25 Spinning Top Other 1.36%
Apr 25 Upper Bollinger Band Walk Other 1.36%
Apr 25 Cup with Handle Other 1.36%
Apr 25 Jack-in-the-Box Bullish Bullish Swing Setup 1.36%
Apr 24 Stochastic Reached Overbought Other 1.29%

Older signals for ABMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 132.95
52 Week Low 92.03
Average Volume 73,093,658
200-Day Moving Average 118.0885
50-Day Moving Average 122.4874
20-Day Moving Average 125.4775
10-Day Moving Average 125.928
Average True Range 2.4952
ADX 26.99
+DI 29.1
-DI: 19.79
Chandelier Exit (Long, 3 ATRs) 124.1944
Chandelier Exit (Short, 3 ATRs) 124.8456
Upper Bollinger Band 130.6406
Lower Bollinger Band 120.3144
Percent B (%b) 1.03
Bandwidth 0.082295